LataMed AI is trading 13.17% down at $0.23 after no company-specific catalyst was identified for September 17, 2026.
- The decline follows consecutive losses on September 15, September 14, and September 11, despite broader markets rallying.
- The move is not clearly explained by overall market sentiment.
- The latest identified company news was a September 9 cooperation agreement involving Venezuelan health ministries, which does not directly explain the current decline.